Session Information
-
WCLC 2019
2019 World Conference on Lung Cancer
Conference Program for the 2019 World Conference on Lung Cancer in Barcelona, Spain
Presentation Date(s):- Sept 7 - 10, 2019
- Total Presentations: 2970
September 7 Sat
Sep 7 Sunday
September 8 Sun
Sep 8 Monday
September 9 Mon
Sep 9 Tuesday
September 10 Tue
Sep 10
-
+
ES02 - Management of Oncogene Addicted Patients with Stage III NSCLC
- 10:30 - 12:00
- 9/08/2019
- Location: Vancouver (2003)
- IASLC CME Accredited
- Type: Educational Session
- Track: Treatment of Locoregional Disease - NSCLC
- Moderators:Carlos Camps, Helena A Yu
-
+
ES02.01 - Biomarker Testing in LA Disease
10:30 - 10:45 | Presenter: Helena A Yu
- Abstract
Loading... -
+
ES02.02 - Management of EGFR LA Disease
10:45 - 11:00 | Presenter: Keunchil Park
- Abstract
Loading... -
+
ES02.03 - Management of Other Non EGFR Oncogene Addicted Tumors
11:00 - 11:15 | Presenter: Charu Aggarwal
- Abstract
Loading... -
+
ES02.04 - Concurrent, Sequential and Combination Immunotherapy Regimens in LA-NSCLC
11:15 - 11:30 | Presenter: Mariano Provencio
- Abstract
Loading... -
+
ES02.05 - Q&A
11:30 - 12:00
- Abstract
No abstract available for this presentation
-
+
MA08 - Pawing the Way to Improve Outcomes in Stage III NSCLC
- 15:15 - 16:45
- 9/08/2019
- Location: Tokyo (1982)
- IASLC CME Accredited
- Type: Mini Oral Session
- Track: Treatment of Locoregional Disease - NSCLC
- Moderators:Simon Ekman, Helena A Yu
-
+
MA08.01 - Analysis of PD-L1 Expression on Circulating Stromal and Tumor Cells in Lung Cancer Patients Treated with Chemoradiation Therapy and Atezolizumab
15:15 - 15:20 | Presenter: Steven H Lin | Author(s): Alexander Augustyn, Jianzhong He, Yawei Qiao, Zhongxing Liao, Ashvathi Raghavakaimal, Kirby Gardner, John Victor Heymach, Anne Tsao, Daniel Adams
- Abstract
Loading... -
+
MA08.02 - Durvalumab Impact in the Treatment Strategy of Stage III Non-Small Cell Lung Cancer (NSCLC): An EORTC Young Investigator Lung Cancer Group Survey
15:20 - 15:25 | Presenter: Matteo Giaj Levra | Author(s): Justin Benet, Baktiar Hasan, Thierry Berghmans, Alessio Bruni, Anne Marie Clasina Dingemans, Niccolo' Giaj Levra, John G Edwards, Corinne Faivre-Finn, Nicolas Girard, Elisa Gobbini, Laurent Greillier, Lizza Hendriks, Sylvie Lantuejoul, Antonin Levy, Silvia Novello, Mary O'Brien, Martin Reck, Alessia Pochesci, Jessica Menis, Benjamin Besse
- Abstract
Loading... -
+
MA08.03 - Adjuvant Pembrolizumab in N2 Positive NSCLC Treated with Concurrent Chemoradiotherapy Followed by Surgery: Phase II, Prospective Study
15:25 - 15:30 | Presenter: Sehhoon Park | Author(s): Hyun Ae Jung, Jong Ho Cho, Jong-Mu Sun, Hong Kwan Kim, Se-Hoon Lee, Yong Soo Choi, Jin Seok Ahn, Jhingook Kim, Keunchil Park, Jae Ill Zo, Young Mog Shim, Myung-Ju Ahn
- Abstract
Loading... -
+
MA08.04 - Discussant - MA08.01, MA08.02, MA08.03
15:30 - 15:45 | Presenter: Delvys Rodriguez-Abreu
- Abstract
No abstract available for this presentation
-
+
MA08.05 - A Multi-Center Analysis of Right vs Left-Sided Pneumonectomy Following Induction Therapy
15:45 - 15:50 | Presenter: Chi-Fu Jeffrey Jeffrey Yang | Author(s): Nicholas R Mayne, Athar Battoo, Sai Yendamuri, Todd Demmy, Robert McKenna, Thomas A D’amico, Mark Berry
- Abstract
Loading... -
+
MA08.06 - Perioperative Outcomes of Lung Cancer Patients with Interstitial Pneumonia
15:50 - 15:55 | Presenter: Aki Katarina Kobayashi | Author(s): Yu Okubo, Masaya Yotsukura, Yukihiro Yoshida, Kazuo Nakagawa, Noriko Motoi, Shun-ichi Watanabe
- Abstract
Loading... -
+
MA08.07 - The Concordance Between Patient Reported Outcomes and Clinician Reported Outcomes During Radiotherapy in Lung Cancer Patients
15:55 - 16:00 | Presenter: Evalien Veldhuijzen | Author(s): Iris Walraven, Margriet Kwint, Laura Roose, José Belderbos, Tomas Janssen
- Abstract
Loading... -
+
MA08.08 - Discussant - MA08.05, MA08.06, MA08.07
16:00 - 16:15 | Presenter: Norihiko Ikeda
- Abstract
No abstract available for this presentation
-
+
MA08.09 - Results of Trimodality Therapy for Patients with cN2 Lung Cancer Diagnosed by Video-Assisted Mediastinoscopic Lymphadenectomy (VAMLA)
16:15 - 16:20 | Presenter: Sergi Call | Author(s): Carme Obiols, Ramon Rami-Porta, Silvia Catot, Miriam Nuñez, Marc Campayo, Francisco Perez Ochoa, Mireia Serra-Mitjans, Jose Belda-Sanchis
- Abstract
Loading... -
+
MA08.10 - Early and Late Outcomes After Surgery for pT4 NSCLC Reclassified by AJCC 8th Edition Criteria
16:20 - 16:25 | Presenter: Jack G Mouhanna | Author(s): Amit Katz, Pierre O Fiset, Roni F Rayes, Aya Siblini, Emma Lee, Andrew Seely, Christian Sirois, David Mulder, Jonathan Cools-Lartigue, Lorenzo E. Ferri, Jonathan D. Spicer
- Abstract
Loading... -
+
MA08.11 - SLCG SCAT Trial: Surgical Audit to Lymph Node Assessment Based on IASLC Recommendations
16:25 - 16:30 | Presenter: Jose Ramon Jarabo Sarceda | Author(s): SERGIO Bolufer, Roberto Mongil, Pedro Lopez De Castro, RAMON Moreno, JUAN CARLOS PeÑalver, Raúl Embún, Joaquín Pac, Francisco Javier Algar, Pablo Gámez, Marcelo Jiménez, Gabriel Sales, Eva Pereira, Bartomeu Massuti, Mariano Provencio, Florentino Hernando-Trancho
- Abstract
Loading... -
+
MA08.12 - Discussant - MA08.09, MA08.010, MA08.11
16:30 - 16:45 | Presenter: Leah Backhus
- Abstract
No abstract available for this presentation
-
+
P1.01 - Advanced NSCLC
- 09:45 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Advanced NSCLC
-
+
P1.01-89 - A Multicenter Phase 1/2a Trial of CLN-081 in NSCLC with EGFR Exon 20 Insertion Mutations
09:45 - 09:45 | Presenter: Zofia Piotrowska | Author(s): David Planchard, Myles Steven Clancy, David Witter, Leigh Zawel, Helena A Yu
- Abstract
Loading...
-
+
P1.14 - Targeted Therapy
- 09:45 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Targeted Therapy
-
+
P1.14-06 - Tissue-Based Molecular and Histologic Landscape of Acquired Resistance to Osimertinib in Patients with EGFR-Mutant Lung Cancers
09:45 - 09:45 | Presenter: Adam J Schoenfeld | Author(s): Joseph Chan, Hira Rizvi, Romel Somwar, Daisuke Kubota, Yahya Daneshbod, Jason Chang, Michael Offin, Maria E. Arcila, Dana Pe'Er, Mark G Kris, Natasha Rekhtman, Gregory J Riely, Marc Ladanyi, Helena A Yu
- Abstract
Loading...
-
+
P2.01 - Advanced NSCLC
- 10:15 - 18:15
- 9/09/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Advanced NSCLC
-
+
P2.01-22 - ORCHARD: A Phase II Platform Study in Patients with Advanced NSCLC Who Have Progressed on First-Line Osimertinib Therapy
10:15 - 10:15 | Presenter: Helena A Yu | Author(s): Sarah B. Goldberg, Xiuning Le, Zofia Piotrowska, Paul Smith, Ilhem Mensi, Bistra Kirova, Juliann Chmielecki, Xiaocheng Li-Sucholeicki, Philip Szekeres, Gail Doughton, Gargi Patel, Philip J Jewsbury, Jonathan W. Riess
- Abstract
Loading...
-
+
MA21 - Non EGFR/MET Targeted Therapies
- 14:30 - 16:00
- 9/10/2019
- Location: Vienna (2016)
- IASLC CME Accredited
- Type: Mini Oral Session
- Track: Targeted Therapy
- Moderators:Benjamin Besse, Michael Thomas
-
+
MA21.06 - Preliminary Phase 1 Results of U3-1402 — A Novel HER3-Targeted Antibody–Drug Conjugate—in EGFR TKI-Resistant, EGFR-Mutant NSCLC
15:05 - 15:10 | Presenter: Helena A Yu | Author(s): Melissa Johnson, Conor E Steuer, Michele Vigliotti, Shuquan Chen, Yasuki Kamai, Channing Yu, Pasi A Jänne
- Abstract
Loading...